Photo from wikipedia
Rituximab is an effective treatment for pemphigus and can be considered as a first-line treatment for severe cases.1-4 Rituximab increases the risk of infection with Pneumocystis jiroveci pneumonia (PJP), an… Click to show full abstract
Rituximab is an effective treatment for pemphigus and can be considered as a first-line treatment for severe cases.1-4 Rituximab increases the risk of infection with Pneumocystis jiroveci pneumonia (PJP), an opportunistic pathogen, especially in hematopoietic stem cell transplant and Wegener's granulomatosis, with a high associated mortality rate up to 30%.5 The risk of PJP infection in pemphigus patients treated with rituximab has been underreported to date. This article is protected by copyright. All rights reserved.
Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!